iANTHUS CAPITAL HOLDINGS (ITHUF) Operating Expenses (2020 - 2026)
iANTHUS CAPITAL HOLDINGS's (ITHUF) quarterly Operating Expenses came in at $18.2 million in Q1 2026, down 12.81% year-on-year from $20.9 million in Q1 2025, and down 3.52% quarter-over-quarter from $18.9 million in Q4 2025.
iANTHUS CAPITAL HOLDINGS (ITHUF) Operating Expenses (2020 - 2026) Analysis & Trends
iANTHUS CAPITAL HOLDINGS has disclosed Operating Expenses across 7 years of filings, most recently posting $18.2 million for Q1 2026.
- Operating Expenses for Q1 2026 came in at $18.2 million, down 12.81% year-over-year; the trailing twelve-month figure through Mar 2026 was $78.4 million (down 4.75% YoY), and the FY2025 annual result was $81.1 million, down 3.01% from the prior year.
- Operating Expenses came in at $18.2 million for Q1 2026 at iANTHUS CAPITAL HOLDINGS, down from $18.9 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $65.1 million in Q2 2022 to a low of $18.2 million in Q1 2026.
- The 5-year median for Operating Expenses is $21.9 million (2023), against an average of $27.2 million.
- Across the five-year window, Operating Expenses jumped 114.28% in 2022 and slumped 62.8% in 2023, its largest moves.
- iANTHUS CAPITAL HOLDINGS's Operating Expenses stood at $60.0 million in 2022, then sank by 62.57% to $22.5 million in 2023, then dropped by 5.59% to $21.2 million in 2024, then decreased by 10.99% to $18.9 million in 2025, then fell by 3.52% to $18.2 million in 2026.
- The last three Operating Expenses figures came in at $18.2 million (Q1 2026), $18.9 million (Q4 2025), and $19.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 526.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 788.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 455.70 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 19.40 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 621.10 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 478.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 441.19 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 96.91 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 475.11 Mn |
| 10 | iANTHUS CAPITAL HOLDINGS | - | - | 15.92 Mn | 18.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.21 Mn |
| Dec 31, 2025 | 18.88 Mn |
| Sep 30, 2025 | 19.83 Mn |
| Jun 30, 2025 | 21.52 Mn |
| Mar 31, 2025 | 20.89 Mn |
| Dec 31, 2024 | 21.21 Mn |
| Sep 30, 2024 | 19.34 Mn |
| Jun 30, 2024 | 20.92 Mn |
| Mar 31, 2024 | 22.16 Mn |
| Dec 31, 2023 | 22.46 Mn |
| Sep 30, 2023 | 21.88 Mn |
| Jun 30, 2023 | 24.22 Mn |
| Mar 31, 2023 | 24.84 Mn |
| Dec 31, 2022 | 60.02 Mn |
| Sep 30, 2022 | 29.91 Mn |
| Jun 30, 2022 | 65.09 Mn |
| Mar 31, 2022 | 31.87 Mn |
| Dec 31, 2021 | 40.77 Mn |
| Sep 30, 2021 | 30.84 Mn |
| Jun 30, 2021 | 30.38 Mn |